Works matching IS 03065251 AND DT 1986 AND VI 21 AND IP 3
1
- British Journal of Clinical Pharmacology, 1986, v. 21, n. 3, p. 334, doi. 10.1111/j.1365-2125.1986.tb05201.x
- Webb, D.;
- Buss, DC;
- Fifield, R.;
- Bateman, DN;
- Routledge, PA
- Article
2
- British Journal of Clinical Pharmacology, 1986, v. 21, n. 3, p. 295, doi. 10.1111/j.1365-2125.1986.tb05193.x
- Downey, KM;
- Chaput de Saintonge, DM
- Article
3
- British Journal of Clinical Pharmacology, 1986, v. 21, n. 3, p. 322, doi. 10.1111/j.1365-2125.1986.tb05197.x
- Adjepon-Yamoah, KK;
- Woolhouse, NM;
- Prescott, LF
- Article
4
- British Journal of Clinical Pharmacology, 1986, v. 21, n. 3, p. 331, doi. 10.1111/j.1365-2125.1986.tb05200.x
- Johnston, A.;
- Marsden, JT;
- Hla, KK;
- Henry, JA;
- Holt, DW
- Article
5
- British Journal of Clinical Pharmacology, 1986, v. 21, n. 3, p. 340, doi. 10.1111/j.1365-2125.1986.tb05204.x
- Giudicelli, JF;
- Berdeaux, A.
- Article
6
- British Journal of Clinical Pharmacology, 1986, v. 21, n. 3, p. 289, doi. 10.1111/j.1365-2125.1986.tb05192.x
- Park, BK;
- Choonara, IA;
- Haynes, BP;
- Breckenridge, AM;
- Malia, RG;
- Preston, FE
- Article
7
- British Journal of Clinical Pharmacology, 1986, v. 21, n. 3, p. 319, doi. 10.1111/j.1365-2125.1986.tb05196.x
- Pringle, T.;
- Fox, J.;
- McNeill, JA;
- Kinney, CD;
- Liddle, J.;
- Harron, DW;
- Shanks, RG
- Article
8
- British Journal of Clinical Pharmacology, 1986, v. 21, n. 3, p. 267, doi. 10.1111/j.1365-2125.1986.tb05189.x
- Article
9
- British Journal of Clinical Pharmacology, 1986, v. 21, n. 3, p. 338, doi. 10.1111/j.1365-2125.1986.tb05203.x
- Article
10
- British Journal of Clinical Pharmacology, 1986, v. 21, n. 3, p. 279, doi. 10.1111/j.1365-2125.1986.tb05191.x
- Ilett, KF;
- Nation, RL;
- Tjokrosetio, R.;
- Thompson, WR;
- Oh, TE;
- Cameron, PD
- Article
11
- British Journal of Clinical Pharmacology, 1986, v. 21, n. 3, p. 309, doi. 10.1111/j.1365-2125.1986.tb05195.x
- Rosenkranz, B.;
- Fischer, C.;
- Meese, CO;
- Frolich, JC
- Article
12
- British Journal of Clinical Pharmacology, 1986, v. 21, n. 3, p. 259, doi. 10.1111/j.1365-2125.1986.tb05188.x
- Hashimoto, T.;
- Shiina, A.;
- Toyo-Oka, T.;
- Hosoda, S.;
- Kondo, K.
- Article
13
- British Journal of Clinical Pharmacology, 1986, v. 21, n. 3, p. 328, doi. 10.1111/j.1365-2125.1986.tb05199.x
- Article
14
- British Journal of Clinical Pharmacology, 1986, v. 21, n. 3, p. 337, doi. 10.1111/j.1365-2125.1986.tb05202.x
- Woodcock, BG;
- Kraemer, N.;
- Rietbrock, N.
- Article
15
- British Journal of Clinical Pharmacology, 1986, v. 21, n. 3, p. 271, doi. 10.1111/j.1365-2125.1986.tb05190.x
- Choonara, IA;
- Cholerton, S.;
- Haynes, BP;
- Breckenridge, AM;
- Park, BK
- Article
16
- British Journal of Clinical Pharmacology, 1986, v. 21, n. 3, p. 301, doi. 10.1111/j.1365-2125.1986.tb05194.x
- Edelman, J.;
- Potter, JM;
- Hackett, LP
- Article
17
- British Journal of Clinical Pharmacology, 1986, v. 21, n. 3, p. 249, doi. 10.1111/j.1365-2125.1986.tb05187.x
- Pringle, TH;
- O'Connor, PC;
- McNeill, AJ;
- Finch, MB;
- Riddell, JG;
- Shanks, RG
- Article
18
- British Journal of Clinical Pharmacology, 1986, v. 21, n. 3, p. 325, doi. 10.1111/j.1365-2125.1986.tb05198.x
- Nahata, MC;
- Powell, DA;
- Durrell, DE;
- Miller, MA
- Article